Pharmaceuticals
5 articles
7 AI Advancements for Drug Discovery and Development
Artificial intelligence identified a novel liver cancer drug candidate in just 30 days, a speed traditionally achieved over years.
AI Advancements Revolutionizing Regenerative Medicine
Insilico Medicine's Rentosertib, an oral small-molecule inhibitor for idiopathic pulmonary fibrosis (IPF), progressed from discovery to a Phase III clinical trial in record time.
Insilico and SK Biopharm Advance AI Drug Discovery
Insilico Medicine's lead drug, INS018_055, reached Phase II trials in 2026, marking it as the first generative AI-designed drug for an AI-discovered target to achieve this milestone.
How Machine Learning Speeds Drug Discovery in Clinical Trials
80% of clinical trials miss their timelines, imposing daily costs of up to $8 million on pharmaceutical companies, according to Nature .
Boehringer Ingelheim to Establish London AI Center
Boehringer Ingelheim is committing £150 million over the next decade to establish a new artificial intelligence and machine learning center in London, aiming to staff it with 50 experts by 2027, accor